Modulation of enzymatic activity of human mast cell tryptase and chymase by protease inhibitors

Acta Pharmacologica Sinica

Volumn 24, Issue 9, 2003, Pages 923-929+951

  He, Shao Heng ^a   Chen, Pu ^a   Chen, Han Qiu ^a  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Chymase; Lactoferrin; Mast cells; Protease inhibitors; Tryptase

Indexed keywords

ALPHA 1 ANTITRYPSIN; ANTIPAIN; BENZAMIDINE; BENZYLOXYCARBONYLISOLEUCYLGLUTAMYLPROLYLPHENYLALANYLCARBOXY DIMETHYL ESTER; CHYMASE; CHYMOSTATIN; LACTOFERRIN; LEUPEPTIN; N (1 HYDROXY 2 NAPHTHOYL)ARGINYLPROLINAMIDE; PROTAMINE; PROTEINASE INHIBITOR; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; SOYBEAN TRYPSIN INHIBITOR; TRYPTASE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; ENZYME ISOLATION; ENZYME SPECIFICITY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG PARENCHYMA; MAST CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; SKIN CULTURE;

ALPHA 1-ANTITRYPSIN; CHYMASES; HUMANS; LEUPEPTINS; LUNG; MAST CELLS; PROTEASE INHIBITORS; SERINE ENDOPEPTIDASES; SKIN; TRYPTASES;

EID: 0042819735     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Abraham WM. Tryptase: potential role in airway inflammation and remodelling. Am J Physiol Lung Cell Mol Physiol 2002; 282: L193-6.
2. McEuen AR, He S, Brander ML, Walls AF. Guinea pig lung tryptase: localisation to mast cells and characterisation of the partially purified enzyme. Biochem Pharmacol 1996; 52: 331-40.
3. Schwartz LB, Lewis RA, Seldin D, Austen KF. Acid hydrolases and tryptase from secretory granules of dispersed human lung mast cells. J Immunol 1981; 126: 1290-4.
4. Ludolph-Hauser D, Rueff F, Fries C, Schopf P, Przybilla B. Constitutively raised serum concentrations of mast-cell tryptase and severe anaphylactic reactions to Hymenoptera stings. Lancet 2001; 357: 361-2.
5. Swystun VA, Gordon JR, Davis EB, Zhang X, Cockcroft DW. Mast cell tryptase release and asthmatic responses to allergen increase with regular use of salbutamol. J Allergy Clin Immunol 2000; 106: 57-64.
6. Bruno G, Andreozzi P, Bracchitta S, Graf U, Santangelo G, Zaino S, et al. Serum tryptase in allergic rhinitis: effect of cetirizine and fluticasone propionate treatment. Clin Ter 2001; 152: 299-303.
7. Buckley MG, Walters C, Brander M, Wong WM, Cawley MI, Ren S, et al. Mast cell activation in arthritis: detection of α and β tryptase, histamine and eosinophil cationic protein in synovial fluid. Clin Sci 1997; 93: 363-70.
8. Walls AF. Structure and function of human mast cell tryptase. In: Marone G, editor. Mast cells and basophils. New York: Academic Press; 2000. p 291-309.
9. He S, Walls AF. Human mast cell tryptase: a potent stimulus of microvascular leakage and mast cell activation. Eur J Pharmacol 1997; 328: 89-97.
10. Molinari JF, Scuri M, Moore WR, Clark J, Tanaka R, Abraham WM. Inhaled tryptase causes bronchoconstriction in sheep via histamine release. Am J Respir Crit Care Med 1996; 154: 649-53.
11. He S, Peng Q, Walls AF. Potent induction of neutrophil- and eosinophil-rich infiltrate in vivo by human mast cell tryptase: selective enhancement of eosinophil recruitment by histamine. J Immunol 1997; 159: 6216-25.
12. Cairns JA, Walls AF. Mast cell tryptase is a mitogen for epithelial cells: stimulation of IL-8 production and intercellular adhesion molecule-1 expression. J Immunol 1996; 156: 275-83.
13. Krishnaswamy G, Kelley J, Johnson D, Youngberg G, Stone W, Huang SK, et al. The human mast cell: functions in physiology and disease. Front Biosci 2001; 6: D1109-27.
14. He S, Walls AF. The induction of a prolonged increase in microvascular permeability by human mast cell chymase. Eur J Pharmacol 1998; 352: 91-8.
15. He S, Walls AF. Human mast cell chymase induces the accumulation of neutrophils, eosinophils and other inflammatory cells in vivo. Br J Pharmacol 1998; 124: 1491-500.
16. Mizutani H, Schechter NM, Lazarus GS, Black RA, Kupper TS. Rapid and specific conversion of precursor interleukin 1β (IL-1β) to an active IL-1 species by human mast cell chymase. J Exp Med 1991; 174: 821-25.
17. He S, Gaga MDA, McEuen AR, Walls AF. Inhibitors of chymase as mast cell stabilising agents: The contribution of chymase in the activation of human mast cells. J Pharmacol Exp Ther 1999; 291: 517-23.
18. + T lymphocyte, interleukin-5, and interferon gamma in induced sputum of asthmatic subjects. Acta Pharmacol Sin 2002; 23: 267-72.
19. Lorentz A, Schwengberg S, Mierke C, Manns MP, Bischoff SC. Human intestinal mast cells produce IL-5 in vitro upon IgE receptor cross-linking and in vivo in the course of intestinal inflammatory disease. Eur J Immunol 1999; 29: 1496-503.
20. Eleno N, Gajate E, Macias J, Garay RP. Enhancement by reproterol of the ability of disodium cromoglycate to stabilize rat mastocytes. Pulm Pharmacol Ther 1999; 12: 55-60.
21. Faller B, Mely Y, Gerard D, Bieth JG. Heparin-induced conformational change and activation of mucus proteinase inhibitor. Biochemistry 1992; 31: 8285-90.
22. Schwartz LB, Bradford TR. Regulation of tryptase from human lung mast cells by heparin: stabilisation of the active tetramer. J Biol Chem 1986; 261: 7372-9.
23. Schechter NM, Fräki JE, Geesin JC, Lazarus GS. Human skin chymotryptic proteinase: isolation and relation to cathepsin G and rat mast cell proteinase I. J Biol Chem 1983; 258: 2973-8.
24. Sukenaga Y, Kido H, Neki A, Enomoto M, Ishida K, Takagi K, et al. Purification and molecular cloning of chymase from human tonsils. FEBS 1993; 323: 119-22.
25. Clark JM, Abraham WM, Fishman CE, Forteza R, Ahmed A, Cortes A, et al. Tryptase inhibitors block allergen-induced airway and inflammatory responses in allergic sheep. Am J Respir Crit Care Med 1995; 152: 2076-83.
26. Blackberg M, Berling R, Ohlsson K. Tissue kallikrein in severe acute pancreatitis in patients treated with high-dose intraperitoneal aprotinin. Pancreas 1999; 19: 325-34.
27. Brinkmann T, Schnierer S, Tschesche H. Recombinant aprotinin homologue with new inhibitory specificity for cathepsin G. Eur J Biochem 1991; 202: 95-9.
28. Hallgren J, Estrada S, Karlson U, Alving K, Pejler G. Heparin antagonists are potent inhibitors of mast cell tryptase. Biochemistry 2001; 40: 7342-9.
29. Bastos M, Maeji NJ, Abeles RH. Inhibitors of human heart chymase based on a peptide library. Proc Natl Acad Sci USA 1995; 92: 6738-42.
30. Barrios VE, Middleton SC, Kashem MA, Havill AM, Toombs CF, Wright CD. Tryptase mediates hyperresponsiveness in isolated guinea pig bronchi. Life Sci 1998; 63: 2295-303.
31. Fath MA, Wu X, Hileman RE, Linhardt RJ, Kashem MA, Nelson RM, et al. Interaction of secretory leukocyte protease inhibitor with heparin inhibits proteases involved in asthma. J Biol Chem 1998; 273: 13563-9.
32. Elrod KC, Moore WR, Abraham WM, Tanaka RD. Lactoferrin, a potent tryptase inhibitor, abolishes late-phase airway responses in allergic sheep. Am J Respir Crit Care Med 1997; 156: 375-81.
33. Pejler G. Lactoferrin regulates the activity of heparin proteoglycan-bound mast cell chymase: characterization of the binding of heparin to lactoferrin. Biochem J 1996; 320: 897-903.